Consensus STAAR Surgical Company Deutsche Boerse AG

Equities

SR3

US8523123052

Market Closed - Deutsche Boerse AG 02:05:14 2024-07-12 am EDT 5-day change 1st Jan Change
43.4 EUR +2.75% Intraday chart for STAAR Surgical Company +9.02% +50.22%

Evolution of the average Target Price on STAAR Surgical Company

Price target over the last 5 years

History of analyst recommendation changes

d883ba2370f380f.DhOSeUZUjZOv8wPNTC77537vsN8kW3syWUcrKHek0uI.Y3zIE34wwcblt1mcIHG8nhjX1oYTajBQbHBFegH2htRoe9NOEme9o_q0YA~ea6290408cae81f7b0ff51c3784f8619
BTIG Upgrades STAAR Surgical to Buy From Neutral, Price Target is $46 MT
Mizuho Adjusts STAAR Surgical's Price Target to $55 From $53, Keeps Buy Rating MT
Morgan Stanley Raises Price Target on STAAR Surgical to $50 From $35, Keeps Equalweight Rating MT
Mizuho Adjusts Price Target on STAAR Surgical to $53 From $45, Maintains Buy Rating MT
Canaccord Genuity Raises Price Target on STAAR Surgical to $46 From $32, Maintains Hold Rating MT
Stifel Upgrades STAAR Surgical to Buy From Hold, Raises Price Target to $50 From $30 MT
Mizuho Securities Adjusts Price Target on STAAR Surgical to $45 From $50, Keeps Buy Rating MT
Piper Sandler Cuts STAAR Surgical Price Target to $33 From $40, Maintains Neutral Rating MT
Needham Downgrades STAAR Surgical to Hold From Buy MT
Morgan Stanley Initiates STAAR Surgical at Equal-Weight Rating With $35 Price Target MT
Needham Adjusts Price Target on STAAR Surgical Company to $49 From $52, Keeps Buy Rating MT
Stifel Lowers Price Target on STAAR Surgical to $40 From $45, Maintains Hold Rating MT
Piper Sandler Adjusts Price Target on STAAR Surgical Company to $45 From $50, Keeps Neutral Rating MT
Canaccord Genuity Adjusts STAAR Surgical Price Target to $43 From $48, Maintains Hold Rating MT
Needham Cuts STAAR Surgical's Price Target to 52 From $54, Keeps Buy Rating MT
Benchmark Downgrades STAAR Surgical to Hold From Buy MT
Stifel Adjusts Price Target on STAAR Surgical Company to $45 From $50, Maintains Hold Rating MT
Needham Adjusts Price Target on STAAR Surgical to $58 From $75, Maintains Buy Rating MT
Canaccord Genuity Downgrades STAAR Surgical to Hold From Buy, Adjusts Price Target to $48 From $77 MT
ANALYST RECOMMENDATIONS : Ferrari, Qualcomm, Zillow, Roku, Southwest Airlines... Our Logo
Stifel Cuts Price Target on STAAR Surgical to $55 From $60, Maintains Hold Rating MT
William Blair Downgrades STAAR Surgical Company to Market Perform From Outperform MT
Needham Adjusts Price Target on STAAR Surgical to $84 From $78, Maintains Buy Rating MT
Piper Sandler Starts STAAR Surgical at Neutral With $65 Price Target MT
ANALYST RECOMMENDATIONS : Biogen, Diageo, HP, Meta, Wolfspeed... Our Logo
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
47.11 USD
Average target price
51.77 USD
Spread / Average Target
+9.89%
High Price Target
60 USD
Spread / Highest target
+27.36%
Low Price Target
40 USD
Spread / Lowest Target
-15.09%

Consensus detail

Consensus revision (last 18 months)

Analysts covering STAAR Surgical Company

BTIG
Morgan Stanley
Mizuho Securities
Canaccord Genuity
Stifel Nicolaus
Piper Sandler
Needham & Co.
Benchmark Company
William Blair & Co.
Sidoti & Co.
Stephens Inc.
Jefferies & Co.
Benchmark Capital
Oppenheimer
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
  1. Stock Market
  2. Equities
  3. STAA Stock
  4. SR3 Stock
  5. Consensus STAAR Surgical Company